Viewing Study NCT03190967


Ignite Creation Date: 2025-12-25 @ 12:38 AM
Ignite Modification Date: 2026-05-25 @ 12:39 PM
Study NCT ID: NCT03190967
Status: TERMINATED
Last Update Posted: 2023-10-11
First Post: 2017-06-16
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: T-DM1 Alone Versus T-DM1 and Metronomic Temozolomide in Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases Following Stereotactic Radiosurgery
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
None Brain Metastasis View
None Brain Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Ado-trastuzumab Emtansine View
None Systemic Control of Disease View
None Maximum Tolerated Dose View
None Preventing the Formation of a Metastasis View